Last reviewed · How we verify
NCT03990922
CTPVB for Hepatectomy
NA trial testing Continuous Paravertebral block with ropivacaine in Pain Management in 76 participants. Completed in 17 November 2019.
9 November 2019
Quick facts
| Lead sponsor | Cui Xulei |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 76 |
| Start date | 20 June 2019 |
| Primary completion | 9 November 2019 |
| Estimated completion | 17 November 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Continuous Paravertebral block with ropivacaine
- Continuous Paravertebral "block" with saline
- Patient-controlled analgesia with morphine — full drug profile →
Conditions studied
- Pain Management — all drugs for Pain Management →
- Paravertebral Block — all drugs for Paravertebral Block →
- Hepatectomy — all drugs for Hepatectomy →
Sponsor
Cui Xulei — full company profile →
Who can join
Adults 18 to 70, any sex, with Pain Management or Paravertebral Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Moderate to severe postoperative pain often influence patients quality of recovery after hepatectomy. Systemic opioids given with patient-controlled analgesia has been used after hepatectomy in many medical center, but the analgesic effect can be limited and undesirable side effects may bring about negative effects on patients recovery. Regional block has been proved to improve patients postoperative recovery in many kinds of surgeries. The investigators therefore designed a prospective, randomized, subject and assessor blinded, parallel-group, placebo controlled study to test the hypothesis that continuous right thoracic paravertebral block increase patients quality of recovery score on the 7th postoperative day after hepatectomy in patients receiving i.v. patient-controlled analgesia (PCA) with morphine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03990922
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous Paravertebral block with ropivacaine
Trials testing the same drug.
- NCT03777644 — Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy · NA · completed
Other recruiting trials for Pain Management
Currently open trials in the same condition.
- NCT07369024 — Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · recruiting
- NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
- NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
- NCT07442539 — The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery · NA · recruiting
Other Cui Xulei trials
Trials by the same sponsor.
- NCT04304274 — Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy · NA · completed
- NCT03975296 — QLB Versus PVB for Acute Pain and Quality of Recovery After Laparoscopic Partial Nephrectomy · NA · completed
- NCT03982784 — TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy · NA · completed
- NCT03414281 — TMQLB Versus TPVB for Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery · NA · terminated
- NCT03777644 — Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03990922 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cui Xulei
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03990922.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing